The DOI matches its Crossref record.
Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo
Abstract
To better understand the antigenic requirements for cross-presentation, we compared the in vivo efficiency of presentation of cell-associated vs soluble OVA with the OT-I (CD8) and OT-II (CD4) TCR transgenic lines. Cross-presentation of cell-associated OVA was very efficient, requiring as little as 21 ng of OVA to activate OT-II cells and 100-fold less to activate OT-I cells. In contrast, soluble OVA was presented inefficiently, requiring at least 10,000 ng OVA for activation of either T cell subset. Thus, cell-associated OVA was presented 500-fold more efficiently than soluble OVA to CD4 T cells and 50,000-fold more efficiently to CD8 T cells. These data, which represent the first quantitative in vivo analysis of cross-presentation, show that cell-associated OVA is very efficiently presented via the class I pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00365-5 · Cited by 1,773
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Self-citationHoltkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
Walker, L. S. K., Chodos, A., Eggena, M., Dooms, H., & Abbas, A. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030315 · Cited by 588
Cross-presentation in viral immunity and self-tolerance
Heath, W. R., & Carbone, F. R. (2001) · Nature Reviews Immunology · doi:10.1038/35100512 · Cited by 480
Self-citationImmune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ
Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021215 · Cited by 468
Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Self-citationCross‐presentation: underlying mechanisms and role in immune surveillance
Rock, K. L., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00301.x · Cited by 451
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
Nakayama, M., Akiba, H., Takeda, K., Kojima, Y., Hashiguchi, M., Azuma, M., Yagita, H., & Okumura, K. (2009) · Blood · doi:10.1182/blood-2008-10-185884 · Cited by 432
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Burgdorf, S., Schölz, C., Kautz, A., Tampé, R., & Kurts, C. (2008) · Nature Immunology · doi:10.1038/ni.1601 · Cited by 405
Self-citationImmune evasion in human papillomavirus-associated cervical cancer
Tindle, R. W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc700 · Cited by 399
Shen, L., Sigal, L. J., Boes, M., & Rock, K. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.004 · Cited by 391
The dominant role of CD8+dendritic cells in cross-presentation is not dictated by antigen capture
Schnorrer, P., Behrens, G. M. N., Wilson, N. S., Pooley, J. L., Smith, C. M., El-Sukkari, D., Davey, G., Kupresanin, F., Li, M., Maraskovsky, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601956103 · Cited by 383
Self-citationCombining radiotherapy and immunotherapy: A revived partnership
Demaria, S., Bhardwaj, N., McBride, W. H., & Formenti, S. C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.032 · Cited by 375
Wilson, N. S., Behrens, G. M. N., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., Forehan, S. P., Mount, A., Steptoe, R. J., Shortman, K. D., et al. (2006) · Nature Immunology · doi:10.1038/ni1300 · Cited by 373
Self-citationBone marrow as a priming site for T-cell responses to blood-borne antigen
Feuerer, M., Beckhove, P., Garbi, N., Mahnke, Y., Limmer, A., Hommel, M., Hämmerling, G. J., Kyewski, B., Hamann, A., Umansky, V., et al. (2003) · Nature Medicine · doi:10.1038/nm914 · Cited by 353
Marciscano, A. E., Ghasemzadeh, A., Nirschl, T. R., Theodros, D., Kochel, C. M., Francica, B. J., Muroyama, Y., Anders, R. A., Sharabi, A. B., Velarde, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3427 · Cited by 335
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805532107 · Cited by 302
Binder, R. J., & Srivastava, P. K. (2005) · Nature Immunology · doi:10.1038/ni1201 · Cited by 295
Zeelenberg, I. S., Ostrowski, M., Krumeich, S., Bobrie, A., Jancic, C., Boissonnas, A., Delcayre, A., Le Pecq, J.-B., Combadière, B., Amigorena, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3163 · Cited by 286
Metadata
- Authors
- Li, M., Davey, G. M., Sutherland, R. M., Kurts, C., Lew, A. M., Hirst, C., Carbone, F. R., & Heath, W. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05
- Volume
- 166
- Issue
- 10
- Pages
- 6099-6103
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2114256385
- Cited by
- 251
- References
- 0
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.